Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus
- PMID: 1549239
- DOI: 10.1212/wnl.42.3.681
Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus
Abstract
We carried out a prospective study of the prevalence and characteristics of anticardiolipin antibodies (aCL) and migraine on 103 consecutive patients with systemic lupus erythematosus (SLE) derived from three European referral university centers. We also included a control group of 58 patients with migraine not associated with SLE. We interviewed all patients using a data collection form designed to provide a complete record of the clinical characteristics of headache. Fifty-four (52%) patients with SLE suffered recurrent headache. We diagnosed migraine in 32 patients, tension headache in 21, and cluster headache in one. Thirty (29%) patients with SLE had aCL. Migraine was present in five patients with aCL and in 27 patients without aCL (17% versus 37%, p = 0.07). No migraine control patient had aCL. Our study highlights the frequency of headache in SLE, but does not support an association between the presence of aCL and migraine in this disease.
Similar articles
-
Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features.J Neurol. 1991 Oct;238(7):401-7. doi: 10.1007/BF00319860. J Neurol. 1991. PMID: 1960545
-
Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.J Rheumatol. 1991 Aug;18(8):1187-92. J Rheumatol. 1991. PMID: 1941822
-
Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?Clin Rheumatol. 2007 Feb;26(2):154-60. doi: 10.1007/s10067-006-0249-7. Epub 2006 Apr 6. Clin Rheumatol. 2007. PMID: 16598413
-
Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study.Clin Rheumatol. 1991 Sep;10(3):289-93. doi: 10.1007/BF02208692. Clin Rheumatol. 1991. PMID: 1790638
-
[The immune system and primary headache syndromes].Anaesthesist. 2001 Oct;50(10):783-91. doi: 10.1007/s001010100200. Anaesthesist. 2001. PMID: 11702329 Review. German.
Cited by
-
Determination of the Risk Factors Contributing to the Development of Neuropsychiatric Lupus in a Systemic Lupus Erythematosus Cohort.Cureus. 2021 Dec 3;13(12):e20129. doi: 10.7759/cureus.20129. eCollection 2021 Dec. Cureus. 2021. PMID: 35003967 Free PMC article.
-
Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.PLoS One. 2015 Mar 17;10(3):e0119911. doi: 10.1371/journal.pone.0119911. eCollection 2015. PLoS One. 2015. PMID: 25781014 Free PMC article.
-
Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?Immunol Res. 2017 Feb;65(1):230-241. doi: 10.1007/s12026-016-8831-9. Immunol Res. 2017. PMID: 27423434 Review.
-
Prevalence and classification of headache in patients with systemic lupus erythematosus.Clin Rheumatol. 2006 Nov;25(6):850-3. doi: 10.1007/s10067-005-0186-x. Epub 2006 Jan 26. Clin Rheumatol. 2006. PMID: 16437362
-
[Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy].Schmerz. 2007 Oct;21(5):415-23. doi: 10.1007/s00482-006-0520-5. Schmerz. 2007. PMID: 17265016 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases